Literature DB >> 33892664

Five long non-coding RNAs establish a prognostic nomogram and construct a competing endogenous RNA network in the progression of non-small cell lung cancer.

Yong Yu1, Kaiming Ren2.   

Abstract

BACKGROUND: Accumulating evidence has revealed that long non-coding RNAs (lncRNAs) play vital roles in the progression of non-small cell lung cancer (NSCLC). But the relationship between lncRNAs and survival outcome of NSCLC remains to be explored. Therefore, we attempt to figure out their survival roles and molecular connection in NSCLC.
METHODS: By analyzing the transcriptome profiling of NSCLC from TCGA databases, we divided patients into three groups, and identified differentially expressed lncRNAs (DELs) of each group. Next, we explored the prognostic roles of common DELs by univariate and multivariate Cox analysis, Lasson, and Kaplan-Meier analysis. Additionally, we assessed and compared the prognostic accuracy of 5 lncRNAs through ROC curves and AUC values. Ultimately, we detected their potential function by enrichment analysis and molecular connection through establishing a competing endogenous RNA (ceRNA) network.
RESULTS: One hundred ninety-seven common DELs were spotted. And we successfully screened out 5 lncRNAs related to the patient's survival, including LINC01833, AC112206.2, FAM83A-AS1, BANCR, and HOTAIR. Combing with age and AJCC stage, we constructed a nomogram that prognostic prediction was superior to the traditional parameters. Furthermore, 275 qualified mRNAs related to 5 lncRNAs were spotted. Functional analysis indicates that these lncRNAs act key roles in the progression of NSCLC, such as P53 and cell cycle signaling pathway. And ceRNA network also suggests that these lncRNAs are tightly connected with tumor progression.
CONCLUSIONS: A nomogram and ceRNA network based on 5 lncRNAs indicate that there can effectively predict the overall survival of NSCLC and potentially serve as a therapeutic guide for NSCLC.

Entities:  

Keywords:  Long non-coding RNA; NSCLC; Nomogram; Overall survival; ceRNA

Year:  2021        PMID: 33892664     DOI: 10.1186/s12885-021-08207-7

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  33 in total

1.  Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer.

Authors:  Rui Zhang; Yuhong Xia; Zhixin Wang; Jie Zheng; Yafei Chen; Xiaoli Li; Yu Wang; Huaikun Ming
Journal:  Biochem Biophys Res Commun       Date:  2017-06-13       Impact factor: 3.575

2.  A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?

Authors:  Leonardo Salmena; Laura Poliseno; Yvonne Tay; Lev Kats; Pier Paolo Pandolfi
Journal:  Cell       Date:  2011-07-28       Impact factor: 41.582

3.  The Cancer Genome Atlas Pan-Cancer analysis project.

Authors:  John N Weinstein; Eric A Collisson; Gordon B Mills; Kenna R Mills Shaw; Brad A Ozenberger; Kyle Ellrott; Ilya Shmulevich; Chris Sander; Joshua M Stuart
Journal:  Nat Genet       Date:  2013-10       Impact factor: 38.330

4.  Local regulation of gene expression by lncRNA promoters, transcription and splicing.

Authors:  Jesse M Engreitz; Jenna E Haines; Elizabeth M Perez; Glen Munson; Jenny Chen; Michael Kane; Patrick E McDonel; Mitchell Guttman; Eric S Lander
Journal:  Nature       Date:  2016-10-26       Impact factor: 49.962

Review 5.  The rise of regulatory RNA.

Authors:  Kevin V Morris; John S Mattick
Journal:  Nat Rev Genet       Date:  2014-04-29       Impact factor: 53.242

6.  Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer.

Authors:  Guangbing Xiong; Chang Liu; Gang Yang; Mengyu Feng; Jianwei Xu; Fangyu Zhao; Lei You; Li Zhou; Lianfang Zheng; Ya Hu; Xiaowo Wang; Taiping Zhang; Yupei Zhao
Journal:  J Hematol Oncol       Date:  2019-09-12       Impact factor: 17.388

Review 7.  Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer.

Authors:  Yong Tang; Guibin Qiao; Enwu Xu; Yiwen Xuan; Ming Liao; Guilin Yin
Journal:  Onco Targets Ther       Date:  2017-09-12       Impact factor: 4.147

8.  Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer.

Authors:  Xiaogang Shen; Yifeng Bai; Bin Luo; Xiaogang Zhou
Journal:  Biol Res       Date:  2017-10-02       Impact factor: 5.612

9.  lncRNA UCA1 Promotes Gefitinib Resistance as a ceRNA to Target FOSL2 by Sponging miR-143 in Non-small Cell Lung Cancer.

Authors:  Xiliu Chen; Zhongliang Wang; Fan Tong; Xiaorong Dong; Gang Wu; Ruiguang Zhang
Journal:  Mol Ther Nucleic Acids       Date:  2019-11-29       Impact factor: 8.886

View more
  2 in total

1.  Methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit-induced long intergenic non-protein coding RNA 1833 N6-methyladenosine methylation promotes the non-small cell lung cancer progression via regulating heterogeneous nuclear ribonucleoprotein A2/B1 expression.

Authors:  Dongliang Li; Zejun Fu; Chaoqun Dong; Yongming Song
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

2.  A nomogram based on A-to-I RNA editing predicting overall survival of patients with lung squamous carcinoma.

Authors:  Li Liu; Jun Liu; Xiaoliang Deng; Li Tu; Zhuxiang Zhao; Chenli Xie; Lei Yang
Journal:  BMC Cancer       Date:  2022-06-29       Impact factor: 4.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.